APO Research
Talk to an analyst

APO RESEARCH · REPORT

Factor XIII Concentrate

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Factor XIII Concentrate Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

2 January 2026174 pages

Choose your research edition.

Industry ResearchFactor XIII Concentrate Industry Research Report 2026113 pages · $2,950 USDIndustry Growth & TrendsGlobal Factor XIII Concentrate Industry Growth and Trends Forecast to 203270 pages · $3,450 USDMarket StructureGlobal Factor XIII Concentrate Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032174 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Factor XIII Concentrate Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Factor XIII Concentrate Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Factor XIII Concentrate market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Factor XIII Concentrate is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Factor XIII Concentrate is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Factor XIII Concentrate is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Factor XIII Concentrate is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Factor XIII Concentrate include CSL Behring. among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Factor XIII Concentrate market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Factor XIII Concentrate and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Factor XIII Concentrate sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Factor XIII Concentrate market size, projected growth trends, production technologies, key applications, and end-use industries.

Factor XIII Concentrate Segment by Company

CSL Behring

Factor XIII Concentrate Segment by Type

1000IU

1600IU

Factor XIII Concentrate Segment by Application

Hospital

Clinic

Factor XIII Concentrate Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Factor XIII Concentrate market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Factor XIII Concentrate and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Factor XIII Concentrate.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Factor XIII Concentrate market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Factor XIII Concentrate manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Factor XIII Concentrate in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Factor XIII Concentrate in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Factor XIII Concentrate Industry Trends Table 2. Factor XIII Concentrate Industry Drivers Table 3. Factor XIII Concentrate Industry Opportunities and Challenges Table 4. Factor XIII Concentrate Industry Restraints Table 5. Global Factor XIII Concentrate Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Factor XIII Concentrate Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Factor XIII Concentrate Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Factor XIII Concentrate Sales Market Share by Manufacturers Table 9. Global Factor XIII Concentrate Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Factor XIII Concentrate Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Factor XIII Concentrate Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Factor XIII Concentrate Manufacturers, Product Type & Application Table 13. Global Factor XIII Concentrate Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Factor XIII Concentrate by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of 1000IU Table 17. Major Manufacturers of 1600IU Table 18. Global Factor XIII Concentrate Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 19. Global Factor XIII Concentrate Sales by Type (2021-2026) & (K Units) Table 20. Global Factor XIII Concentrate Sales by Type (2027-2032) & (K Units) Table 21. Global Factor XIII Concentrate Sales Market Share by Type (2021-2026) Table 22. Global Factor XIII Concentrate Sales Market Share by Type (2027-2032) Table 23. Global Factor XIII Concentrate Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global Factor XIII Concentrate Revenue by Type (2021-2026) & (K Units) Table 25. Global Factor XIII Concentrate Revenue by Type (2027-2032) & (K Units) Table 26. Global Factor XIII Concentrate Revenue Market Share by Type (2021-2026) Table 27. Global Factor XIII Concentrate Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Hospital Table 29. Major Manufacturers of Clinic Table 30. Global Factor XIII Concentrate Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 31. Global Factor XIII Concentrate Sales by Application (2021-2026) & (K Units) Table 32. Global Factor XIII Concentrate Sales by Application (2027-2032) & (K Units) Table 33. Global Factor XIII Concentrate Sales Market Share by Application (2021-2026) Table 34. Global Factor XIII Concentrate Sales Market Share by Application (2027-2032) Table 35. Global Factor XIII Concentrate Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 36. Global Factor XIII Concentrate Revenue by Application (2021-2026) & (K Units) Table 37. Global Factor XIII Concentrate Revenue by Application (2027-2032) & (K Units) Table 38. Global Factor XIII Concentrate Revenue Market Share by Application (2021-2026) Table 39. Global Factor XIII Concentrate Revenue Market Share by Application (2027-2032) Table 40. Global Factor XIII Concentrate Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 41. Global Factor XIII Concentrate Sales by Region (2021-2026) & (K Units) Table 42. Global Factor XIII Concentrate Sales Market Share by Region (2021-2026) Table 43. Global Factor XIII Concentrate Sales Forecasted by Region (2027-2032) & (K Units) Table 44. Global Factor XIII Concentrate Sales Forecasted Market Share by Region (2027-2032) Table 45. North America Factor XIII Concentrate Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 46. North America Factor XIII Concentrate Sales by Country (2021-2026) & (K Units) Table 47. North America Factor XIII Concentrate Sales by Country (2027-2032) & (K Units) Table 48. Europe Factor XIII Concentrate Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 49. Europe Factor XIII Concentrate Sales by Country (2021-2026) & (K Units) Table 50. Europe Factor XIII Concentrate Sales by Country (2027-2032) & (K Units) Table 51. Asia Pacific Factor XIII Concentrate Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 52. Asia Pacific Factor XIII Concentrate Sales by Country (2021-2026) & (K Units) Table 53. Asia Pacific Factor XIII Concentrate Sales by Country (2027-2032) & (K Units) Table 54. South America, Middle East and Africa Factor XIII Concentrate Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. South America, Middle East and Africa Factor XIII Concentrate Sales by Country (2021-2026) & (K Units) Table 56. South America, Middle East and Africa Factor XIII Concentrate Sales by Country (2027-2032) & (K Units) Table 57. Global Factor XIII Concentrate Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Factor XIII Concentrate Revenue by Region (2021-2026) & (US$ Million) Table 59. Global Factor XIII Concentrate Revenue by Region (2027-2032) & (US$ Million) Table 60. Global Factor XIII Concentrate Revenue Market Share by Region (2021-2026) Table 61. Global Factor XIII Concentrate Revenue Market Share by Region (2027-2032) Table 62. CSL Behring Company Information Table 63. CSL Behring Business Overview Table 64. CSL Behring Factor XIII Concentrate Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 65. CSL Behring Factor XIII Concentrate Product Portfolio Table 66. CSL Behring Recent Development Table 67. Key Raw Materials Table 68. Raw Materials Key Suppliers Table 69. Factor XIII Concentrate Distributors List Table 70. Factor XIII Concentrate Customers List Table 71. Research Programs/Design for This Report Table 72. Authors List of This Report Table 73. Secondary Sources Table 74. Primary Sources List of Figures Figure 1. Factor XIII Concentrate Product Image Figure 2. Global Factor XIII Concentrate Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Factor XIII Concentrate Market Size (2021-2032) & (US$ Million) Figure 4. Global Factor XIII Concentrate Sales (2021-2032) & (K Units) Figure 5. Global Factor XIII Concentrate Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Factor XIII Concentrate Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. 1000IU Image Figure 9. 1600IU Image Figure 10. Global Factor XIII Concentrate Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 11. Global Factor XIII Concentrate Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Factor XIII Concentrate Sales Market Share by Type (2021-2032) Figure 13. Global Factor XIII Concentrate Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Factor XIII Concentrate Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Factor XIII Concentrate Revenue Market Share by Type (2021-2032) Figure 16. Hospital Image Figure 17. Clinic Image Figure 18. Global Factor XIII Concentrate Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 19. Global Factor XIII Concentrate Sales Market Share 2021 VS 2025 VS 2032 Figure 20. Global Factor XIII Concentrate Sales Market Share by Application (2021-2032) Figure 21. Global Factor XIII Concentrate Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 22. Global Factor XIII Concentrate Revenue Market Share 2021 VS 2025 VS 2032 Figure 23. Global Factor XIII Concentrate Revenue Market Share by Application (2021-2032) Figure 24. North America Factor XIII Concentrate Sales and Growth Rate (2021-2032) & (K Units) Figure 25. North America Factor XIII Concentrate Sales Market Share by Country (2021-2032) Figure 26. U.S. Factor XIII Concentrate Sales and Growth Rate (2021-2032) & (K Units) Figure 27. Canada Factor XIII Concentrate Sales and Growth Rate (2021-2032) & (K Units) Figure 28. Mexico Factor XIII Concentrate Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Europe Factor XIII Concentrate Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Europe Factor XIII Concentrate Sales Market Share by Country (2021-2032) Figure 31. Germany Factor XIII Concentrate Sales and Growth Rate (2021-2032) & (K Units) Figure 32. France Factor XIII Concentrate Sales and Growth Rate (2021-2032) & (K Units) Figure 33. U.K. Factor XIII Concentrate Sales and Growth Rate (2021-2032) & (K Units) Figure 34. Italy Factor XIII Concentrate Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Netherlands Factor XIII Concentrate Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Asia Pacific Factor XIII Concentrate Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Asia Pacific Factor XIII Concentrate Sales Market Share by Country (2021-2032) Figure 38. China Factor XIII Concentrate Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Japan Factor XIII Concentrate Sales and Growth Rate (2021-2032) & (K Units) Figure 40. South Korea Factor XIII Concentrate Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Southeast Asia Factor XIII Concentrate Sales and Growth Rate (2021-2032) & (K Units) Figure 42. India Factor XIII Concentrate Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Australia Factor XIII Concentrate Sales and Growth Rate (2021-2032) & (K Units) Figure 44. South America, Middle East and Africa Factor XIII Concentrate Sales and Growth Rate (2021-2032) & (K Units) Figure 45. South America, Middle East and Africa Factor XIII Concentrate Sales Market Share by Country (2021-2032) Figure 46. Brazil Factor XIII Concentrate Sales and Growth Rate (2021-2032) & (K Units) Figure 47. South Africa Factor XIII Concentrate Sales and Growth Rate (2021-2032) & (K Units) Figure 48. Saudi Arabia Factor XIII Concentrate Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Turkey Factor XIII Concentrate Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Argentina Factor XIII Concentrate Sales and Growth Rate (2021-2032) & (K Units) Figure 51. UAE Factor XIII Concentrate Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Egypt Factor XIII Concentrate Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Chile Factor XIII Concentrate Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Global Factor XIII Concentrate Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 55. Global Factor XIII Concentrate Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 56. North America Factor XIII Concentrate Revenue (2021-2032) & (US$ Million) Figure 57. North America Factor XIII Concentrate Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 58. Europe Factor XIII Concentrate Revenue (2021-2032) & (US$ Million) Figure 59. Europe Factor XIII Concentrate Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Asia-Pacific Factor XIII Concentrate Revenue (2021-2032) & (US$ Million) Figure 61. Asia-Pacific Factor XIII Concentrate Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. South America, Middle East and Africa Factor XIII Concentrate Revenue (2021-2032) & (US$ Million) Figure 63. South America, Middle East and Africa Factor XIII Concentrate Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Factor XIII Concentrate Value Chain Figure 65. Manufacturing Cost Structure Figure 66. Factor XIII Concentrate Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • 1000IU
  • 1600IU
Applications
  • Hospital
  • Clinic
Companies covered
  • CSL Behring

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Factor XIII Concentrate Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Factor XIII Concentrate Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Factor XIII Concentrate Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Factor XIII Concentrate Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Factor XIII Concentrate Market Dynamics
  1. 2.1 Factor XIII Concentrate Industry Trends
  2. 2.2 Factor XIII Concentrate Industry Drivers
  3. 2.3 Factor XIII Concentrate Industry Opportunities and Challenges
  4. 2.4 Factor XIII Concentrate Industry Restraints
3 Factor XIII Concentrate Market by Manufacturers
  1. 3.1 Global Factor XIII Concentrate Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Factor XIII Concentrate Sales by Manufacturers (2021-2026)
  3. 3.3 Global Factor XIII Concentrate Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Factor XIII Concentrate Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Factor XIII Concentrate Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Factor XIII Concentrate Manufacturers, Product Type & Application
  7. 3.7 Global Factor XIII Concentrate Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Factor XIII Concentrate Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Factor XIII Concentrate Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Factor XIII Concentrate Tier 1, Tier 2, and Tier 3
4 Factor XIII Concentrate Market by Type
  1. 4.1 Factor XIII Concentrate Type Introduction
  2. 4.1.1 1000IU
  3. 4.1.2 1600IU
  4. 4.2 Global Factor XIII Concentrate Sales by Type
  5. 4.2.1 Global Factor XIII Concentrate Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Factor XIII Concentrate Sales by Type (2021-2032)
  7. 4.2.3 Global Factor XIII Concentrate Sales Market Share by Type (2021-2032)
  8. 4.3 Global Factor XIII Concentrate Revenue by Type
  9. 4.3.1 Global Factor XIII Concentrate Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Factor XIII Concentrate Revenue by Type (2021-2032)
  11. 4.3.3 Global Factor XIII Concentrate Revenue Market Share by Type (2021-2032)
5 Factor XIII Concentrate Market by Application
  1. 5.1 Factor XIII Concentrate Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.2 Global Factor XIII Concentrate Sales by Application
  5. 5.2.1 Global Factor XIII Concentrate Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Factor XIII Concentrate Sales by Application (2021-2032)
  7. 5.2.3 Global Factor XIII Concentrate Sales Market Share by Application (2021-2032)
  8. 5.3 Global Factor XIII Concentrate Revenue by Application
  9. 5.3.1 Global Factor XIII Concentrate Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Factor XIII Concentrate Revenue by Application (2021-2032)
  11. 5.3.3 Global Factor XIII Concentrate Revenue Market Share by Application (2021-2032)
6 Global Factor XIII Concentrate Sales by Region
  1. 6.1 Global Factor XIII Concentrate Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Factor XIII Concentrate Sales by Region (2021-2032)
  3. 6.2.1 Global Factor XIII Concentrate Sales by Region (2021-2026)
  4. 6.2.2 Global Factor XIII Concentrate Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Factor XIII Concentrate Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Factor XIII Concentrate Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Factor XIII Concentrate Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Factor XIII Concentrate Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Factor XIII Concentrate Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Factor XIII Concentrate Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Factor XIII Concentrate Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Factor XIII Concentrate Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Factor XIII Concentrate Revenue by Region
  1. 7.1 Global Factor XIII Concentrate Revenue by Region
  2. 7.1.1 Global Factor XIII Concentrate Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Factor XIII Concentrate Revenue by Region (2021-2026)
  4. 7.1.3 Global Factor XIII Concentrate Revenue by Region (2027-2032)
  5. 7.1.4 Global Factor XIII Concentrate Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Factor XIII Concentrate Revenue (2021-2032)
  8. 7.2.2 North America Factor XIII Concentrate Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Factor XIII Concentrate Revenue (2021-2032)
  11. 7.3.2 Europe Factor XIII Concentrate Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Factor XIII Concentrate Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Factor XIII Concentrate Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Factor XIII Concentrate Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Factor XIII Concentrate Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 CSL Behring
  2. 8.1.1 CSL Behring Company Information
  3. 8.1.2 CSL Behring Business Overview
  4. 8.1.3 CSL Behring Factor XIII Concentrate Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 CSL Behring Factor XIII Concentrate Product Portfolio
  6. 8.1.5 CSL Behring Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Factor XIII Concentrate Value Chain Analysis
  2. 9.1.1 Factor XIII Concentrate Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Factor XIII Concentrate Production Mode & Process
  6. 9.2 Factor XIII Concentrate Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Factor XIII Concentrate Distributors
  9. 9.2.3 Factor XIII Concentrate Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst